Ribociclib succinate hydrate (LEE011 succinate hydrate)
98%
- Product Code: 55986
CAS:
1374639-79-8
| Molecular Weight: | 570.64 g./mol | Molecular Formula: | C₂₇H₃₈N₈O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Ribociclib succinate hydrate is primarily used in the treatment of certain types of breast cancer. It is specifically indicated for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, often in combination with other therapies such as aromatase inhibitors. The compound works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which play a crucial role in cell division and proliferation. By blocking these kinases, it helps to slow down or stop the growth of cancer cells. This targeted approach makes it a valuable option in personalized cancer treatment regimens, improving progression-free survival for patients. It is typically administered orally, offering convenience and flexibility in its use. Ongoing research is exploring its potential in other cancer types and combination therapies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿12,636.00 |
+
-
|
Ribociclib succinate hydrate (LEE011 succinate hydrate)
Ribociclib succinate hydrate is primarily used in the treatment of certain types of breast cancer. It is specifically indicated for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, often in combination with other therapies such as aromatase inhibitors. The compound works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which play a crucial role in cell division and proliferation. By blocking these kinases, it helps to slow down or stop the growth of cancer cells. This targeted approach makes it a valuable option in personalized cancer treatment regimens, improving progression-free survival for patients. It is typically administered orally, offering convenience and flexibility in its use. Ongoing research is exploring its potential in other cancer types and combination therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :